J Kraan

2.5k total citations
39 papers, 1.9k citations indexed

About

J Kraan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, J Kraan has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 13 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in J Kraan's work include Asthma and respiratory diseases (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Respiratory and Cough-Related Research (7 papers). J Kraan is often cited by papers focused on Asthma and respiratory diseases (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Respiratory and Cough-Related Research (7 papers). J Kraan collaborates with scholars based in Netherlands, United States and Italy. J Kraan's co-authors include G H Koëter, Richard van Altena, T W van der Mark, Dirkje S. Postma, H. J. Sluiter, Peter J. Wijkstra, G H Koëter, K. de Vries, DS Postma and Elisabeth M. TenVergert and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

J Kraan

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Kraan Netherlands 18 1.5k 865 171 157 152 39 1.9k
Thomas Glaab Germany 23 1.4k 1.0× 1.2k 1.4× 72 0.4× 63 0.4× 110 0.7× 50 2.1k
Anne Kirsten Germany 18 2.3k 1.5× 1.2k 1.4× 247 1.4× 159 1.0× 316 2.1× 35 2.6k
J.M. Broquetas Spain 19 1.2k 0.8× 511 0.6× 279 1.6× 89 0.6× 93 0.6× 58 1.6k
P Howard United Kingdom 26 2.8k 1.9× 1.1k 1.3× 129 0.8× 123 0.8× 428 2.8× 97 3.4k
Claes-Göran Löfdahl Sweden 14 2.5k 1.7× 2.1k 2.5× 25 0.1× 133 0.8× 54 0.4× 16 2.9k
Marina Aiello Italy 24 1.2k 0.8× 619 0.7× 247 1.4× 44 0.3× 217 1.4× 91 1.9k
Angelina Bockelbrink Germany 20 237 0.2× 279 0.3× 111 0.6× 64 0.4× 144 0.9× 54 1.4k
M A Félez Spain 14 1.1k 0.7× 521 0.6× 92 0.5× 104 0.7× 121 0.8× 27 1.4k
David M. Daughton United States 22 1.1k 0.7× 1.8k 2.1× 19 0.1× 158 1.0× 124 0.8× 48 2.9k
T Kava Finland 16 2.0k 1.4× 2.5k 2.8× 15 0.1× 105 0.7× 36 0.2× 20 3.0k

Countries citing papers authored by J Kraan

Since Specialization
Citations

This map shows the geographic impact of J Kraan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kraan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kraan more than expected).

Fields of papers citing papers by J Kraan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kraan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kraan. The network helps show where J Kraan may publish in the future.

Co-authorship network of co-authors of J Kraan

This figure shows the co-authorship network connecting the top 25 collaborators of J Kraan. A scholar is included among the top collaborators of J Kraan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kraan. J Kraan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ubbels, Jan F., Max Beijert, Harry J.M. Groen, et al.. (2015). An instrument dedicated for modelling of pulmonary radiotherapy. Radiotherapy and Oncology. 115(1). 3–8. 8 indexed citations
2.
Janssen, Koen M. J., Menke J. de Smit, Elisabeth Brouwer, et al.. (2015). Rheumatoid arthritis–associated autoantibodies in non–rheumatoid arthritis patients with mucosal inflammation: a case–control study. Arthritis Research & Therapy. 17(1). 174–174. 57 indexed citations
3.
Jong, W. de, W. M. van Aalderen, J Kraan, G H Koëter, & Cees P. van der Schans. (2001). Inspiratory muscle training in patients with cystic fibrosis. Respiratory Medicine. 95(1). 31–36. 52 indexed citations
4.
Kraan, J, et al.. (2001). The NK‐2 receptor antagonist SR 48968C does not improve adenosine hyperresponsiveness and airway obstruction in allergic asthma. Clinical & Experimental Allergy. 31(2). 274–278. 31 indexed citations
5.
Rijcken, B, Jan P. Schouten, J Kraan, et al.. (1999). The Relationship of Skin Test Positivity, High Serum Total IgE Levels, and Peripheral Blood Eosinophilia to Symptomatic and Asymptomatic Airway Hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine. 159(3). 924–931. 62 indexed citations
6.
Schouten, Jan P., Judith M. Vonk, B Rijcken, et al.. (1999). Smoking and Airway Hyperresponsiveness Especially in the Presence of Blood Eosinophilia Increase the Risk to Develop Respiratory Symptoms: A 25-year Follow-up Study in the General Adult Population. American Journal of Respiratory and Critical Care Medicine. 160(1). 259–264. 42 indexed citations
7.
Visser, Ton J., Aren van Waarde, T W van der Mark, et al.. (1999). Detection of muscarinic receptors in the human lung using PET.. PubMed. 40(8). 1270–6. 9 indexed citations
8.
Visser, Ton J., Aren van Waarde, Petra Doze, et al.. (1998). Characterisation of β2-adrenoceptors, using the agonist []formoterol and positron emission tomography. European Journal of Pharmacology. 361(1). 35–41. 20 indexed citations
9.
Timens, Wim, et al.. (1998). Increased peak expiratory flow variation in asthma: severe persistent increase but not nocturnal worsening of airway inflammation. European Respiratory Journal. 12(3). 546–550. 29 indexed citations
10.
Timens, Wim, et al.. (1997). (A)Symptomatic bronchial hyper-responsiveness and asthma. Respiratory Medicine. 91(3). 121–134. 47 indexed citations
11.
Waarde, Aren van, et al.. (1997). Imaging beta-adrenoceptors in the human brain with (S)-1'-[18F]fluorocarazolol.. PubMed. 38(6). 934–9. 36 indexed citations
12.
Wijkstra, Peter J., T W van der Mark, J Kraan, et al.. (1996). Long-Term Effects of Home Rehabilitation on Physical Performance in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 153(4). 1234–1241. 74 indexed citations
13.
Kraan, J, et al.. (1996). Effects of home rehabilitation on physical performance in patients with chronic obstructive pulmonary disease (COPD). European Respiratory Journal. 9(1). 104–110. 94 indexed citations
14.
Wijkstra, Peter J., Elisabeth M. TenVergert, Richard van Altena, et al.. (1994). Reliability and validity of the chronic respiratory questionnaire (CRQ).. Thorax. 49(5). 465–467. 170 indexed citations
15.
Koëter, G H, et al.. (1989). Effect of theophylline and enprofylline on bronchial hyperresponsiveness.. Thorax. 44(12). 1022–1026. 9 indexed citations
16.
17.
Kraan, J, et al.. (1988). The pharmacokinetics of theophylline and enprofylline in patients with liver cirrhosis and in patients with chronic renal disease. European Journal of Clinical Pharmacology. 35(4). 357–362. 14 indexed citations
18.
Kraan, J, G H Koëter, Martin Boorsma, et al.. (1988). Dosage and Time Effects of Inhaled Budesonide on Bronchial Hyperreactivity. American Review of Respiratory Disease. 137(1). 44–48. 129 indexed citations
19.
Kraan, J, et al.. (1986). CHANGES IN BRONCHIAL HYPERREACTIVITY INDUCED BY 4 WEEKS TREATMENT WITH ANTIASTHMATIC DRUGS IN ALLERGIC ASTHMATIC-PATIENTS - A COMPARISON BETWEEN BUDESONIDE AND TERBUTALINE. Data Archiving and Networked Services (DANS). 69. 1 indexed citations
20.
Kraan, J, et al.. (1959). Indikationen zur Resektion wegen Lungentuberkulose und die Resultate dieser Therapie. Lung. 119(6). 499–515. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Glaab Breakdown of academic impact, for papers by Anne Kirsten Breakdown of academic impact, for papers by J.M. Broquetas Breakdown of academic impact, for papers by P Howard Breakdown of academic impact, for papers by Claes-Göran Löfdahl Breakdown of academic impact, for papers by Marina Aiello Breakdown of academic impact, for papers by Angelina Bockelbrink Breakdown of academic impact, for papers by M A Félez Breakdown of academic impact, for papers by David M. Daughton Breakdown of academic impact, for papers by T Kava
Rankless by CCL
2026